Effect of N-acetylcysteine on exacerbations of bronchiectasis (BENE): a randomized controlled trial

BACKGROUND: N-acetylcysteine is a classic mucolytic agent. This study aimed to investigate the efficacy of N-acetylcysteine on reducing the risk of exacerbations in bronchiectasis patients. METHODS: A prospective, randomized, controlled trial was conducted between April 1, 2014 and December 31, 2016...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Qian, Ailiyaer, Yirepanjaing, Liu, Ruijuan, Zhang, Yan, Li, Caiyu, Liu, Mingtao, Wang, Xiuxiu, Jing, Lijun, Li, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458826/
https://www.ncbi.nlm.nih.gov/pubmed/30975143
http://dx.doi.org/10.1186/s12931-019-1042-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458826/
https://www.ncbi.nlm.nih.gov/pubmed/30975143
http://dx.doi.org/10.1186/s12931-019-1042-x

Ejemplares similares